Eric Hoffman

Children's National Medical Center · Center for Genetic Medicine Research
a
a
a
a
44.39

Topics (11) View all

Publications (257) View all

  • Article: VBP15, a Glucocorticoid Analogue, Is Effective at Reducing Allergic Lung Inflammation in Mice
    PLoS ONE 05/2013; 8(5):e63871. · 4.09 Impact Factor
  • Article: Impaired autophagy, chaperone expression and protein synthesis in response to critical illness interventions in porcine skeletal muscle.
    [show abstract] [hide abstract]
    ABSTRACT: Critical illness myopathy (CIM) is characterized by a preferential loss of the motor protein myosin, muscle wasting and impaired muscle function in critically ill intensive care unit (ICU) patients.CIM is associated with severe morbidity and mortality and has a significant negative socioeconomic effect. Neuromuscular blocking agents, corticosteroids, sepsis, mechanical ventilation and immobilization have been implicated as important risk factors but the causal relationship between CIM and the risk factors has not been established. A porcine ICU model has been used to determine the immediate molecular and cellular cascades that may contribute to the pathogenesis prior to myosin loss and extensive muscle wasting. Expression profiles have been compared between pigs exposed to the ICU interventions, i.e., mechanically ventilated, sedated and immobilized for five days, with pigs exposed to critical illness interventions, i.e., neuromuscular blocking agents (NMBA), corticosteroids and induced sepsis in addition to the ICU condition for five days. Impaired autophagy as well as impaired chaperone expression and protein synthesis were observed in the skeletal muscle in response to critical illness interventions. Impaired core autophagy machinery in response to critical illness is a novel finding in this study, which when in concert with downregulated chaperone expression and protein synthesis may collectively affect the proteostasis in skeletal muscle and may exacerbate the disease progression in CIM.
    Physiological Genomics 04/2013; · 2.73 Impact Factor
  • Article: Effects of corticosteroids in the development of limb muscle weakness in a porcine intensive care unit model.
    [show abstract] [hide abstract]
    ABSTRACT: Severe muscle wasting is a debilitating condition in critically ill intensive care unit (ICU) patients, characterized by general muscle weakness and dysfunction, resulting in a prolonged mobilization, delayed weaning from the ventilator and a decreased quality of life post-ICU. The mechanisms underlying limb muscle weakness in ICU patients are complex and involve the impact of primary disease, but also factors common to critically ill ICU patients such as sepsis, mechanical ventilation (MV), immobilization and systemic administration of corticosteroids (CS). These factors may have additive negative effects on skeletal muscle structure and function, but their respective role alone remain unknown. The primary aim of this study was to examine how CS administration potentiates ventilator and immobilization-related limb muscle dysfunction at the gene level. Comparing biceps femoris gene expression in pigs exposed to MV and CS for five days with only MV pigs for the same duration of time showed a distinct deregulation of 186 genes using microarray. Surprisingly, the decreased force-generation capacity at the single muscle fiber reported in response to the addition of CS administration in mechanically ventilated and immobilized pigs was not associated with an additional up-regulation of proteolytic pathways. On the other hand, an altered expression of genes regulating kinase activity, cell cycle, transcription, channel regulation, oxidative stress response , cytoskeletal, sarcomeric and heat shock protein as well as protein synthesis at the translational level appear to play an additive deleterious role for the limb muscle weakness in immobilized ICU patients.
    Physiological Genomics 02/2013; · 2.73 Impact Factor
  • Article: VBP15: Preclinical characterization of a novel anti-inflammatory delta 9,11 steroid.
    [show abstract] [hide abstract]
    ABSTRACT: Δ9,11 modifications of glucocorticoids (21-aminosteroids) have been developed as drugs for protection against cell damage (lipid peroxidation; lazaroids) and inhibition of neovascularization (anecortave). Part of the rationale for developing these compounds has been the loss of glucocorticoid receptor binding due to the Δ9,11 modification, thus avoiding many immunosuppressive activities and deleterious side effect profiles associated with binding to glucocorticoid and mineralocorticoid receptors. We recently demonstrated that anecortave acetate and its 21-hydroxy analog (VBP1) do, in fact, show glucocorticoid and mineralocorticoid receptor binding activities, with potent translocation of the glucocorticoid receptor to the cell nucleus. We concluded that Δ9,11 steroids showed novel anti-inflammatory properties, retaining NF-κB inhibition, but losing deleterious glucocorticoid side effect profiles. Evidence for this was developed in pre-clinical trials of chronic muscle inflammation. Here, we describe a drug development program aimed at optimizing the Δ9,11 chemistry. Twenty Δ9,11 derivatives were tested in in vitro screens for NF-κB inhibition and GR translocation to the nucleus, and low cell toxicity. VBP15 was selected as the lead compound due to potent NF-κB inhibition and GR translocation similar to prednisone and dexamethasone, lack of transactivation properties, and good bioavailability. Phamacokinetics were similar to traditional glucocorticoid drugs with terminal half-life of 0.35h (mice), 0.58h (rats), 5.42h (dogs), and bioavailability of 74.5% (mice), and 53.2% (dogs). Metabolic stability showed ⩾80% remaining at 1h of VBP6 and VBP15 in human, dog, and monkey liver microsomes. Solubility, permeability and plasma protein binding were within acceptable limits. VBP15 moderately induced CYP3A4 across the three human hepatocyte donors (24-42%), similar to other steroids. VBP15 is currently under development for treatment of Duchenne muscular dystrophy.
    Bioorganic & medicinal chemistry 02/2013; · 2.82 Impact Factor
  • Source
    Article: Microarray Analysis Reveals Novel Features of the Muscle Aging Process in Men and Women.
    [show abstract] [hide abstract]
    ABSTRACT: To develop a global view of muscle transcriptional differences between older men and women and sex-specific aging, we obtained muscle biopsies from the biceps brachii of young and older men and women and profiled the whole-genome gene expression using microarray. A logistic regression-based method in combination with an intensity-based Bayesian moderated t test was used to identify significant sex- and aging-related gene functional groups. Our analysis revealed extensive sex differences in the muscle transcriptome of older individuals and different patterns of transcriptional changes with aging in men and women. In older women, we observed a coordinated transcriptional upregulation of immune activation, extracellular matrix remodeling, and lipids storage; and a downregulation of mitochondrial biogenesis and function and muscle regeneration. The effect of aging results in sexual dimorphic alterations in the skeletal muscle transcriptome, which may modify the risk for developing musculoskeletal and metabolic diseases in men and women.
    The Journals of Gerontology Series A Biological Sciences and Medical Sciences 02/2013; · 4.60 Impact Factor

Followers (60) See all